EMA briefs
The European Medicines Agency (EMA) has released a guideline on validation of bioanalytical methods in pharmaceutical production - see
Bioanalytical methods guideline
EMA and the EU's Heads of Medicines Agencies (HMA) organisation have released recommendations on handling requests for access to periodic safety update reports - see Periodic safety update reports
Meanwhile, EMA has released submission deadlines for advanced therapy medicinal products - see Deadlines for advanced therapy medicinal products and Deadlines for advanced therapy medicinal products
The agency has released a guideline on the clinical development of medicinal products for the treatment of cystic fibrosis - see
Guideline on the clinical development of medicinal products for the treatment of cystic fibrosis;
EMA has released a table of translations required for orphan drug designation applications - see
Table of translations required for orphan drug designation applications
And it has published a draft standard paediatric investigation plan for allergen products for specific immunotherapy - see